BPOP vs GGAL

BPOP's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. Despite strong profitability metrics and robust earnings growth, the lack of Altman Z-Score and missing key financial data (Debt/Equity, cash/debt levels) limits confidence in structural safety. The stock trades below analyst target and intrinsic value estimates but faces headwinds from bearish insider activity and weakening technical momentum. Solid dividend coverage and sector-leading earnings surprises provide offsetting positives.

The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 2/9 and a massive valuation gap where the current price ($47.93) trades at a significant premium to the Graham Number ($8.34) and Intrinsic Value ($6.23). While long-term price performance has been exceptional, current fundamentals show severe deterioration, including a negative YoY revenue growth of 10% and a catastrophic earnings surprise trend (-149.13% over the last 4 quarters). The dividend is unsustainable with a payout ratio of 123.58%, suggesting capital erosion. Despite bullish analyst targets, the hard data indicates a high-risk, overvalued asset.